DK1759711T3 - Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer - Google Patents

Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer

Info

Publication number
DK1759711T3
DK1759711T3 DK05019082T DK05019082T DK1759711T3 DK 1759711 T3 DK1759711 T3 DK 1759711T3 DK 05019082 T DK05019082 T DK 05019082T DK 05019082 T DK05019082 T DK 05019082T DK 1759711 T3 DK1759711 T3 DK 1759711T3
Authority
DK
Denmark
Prior art keywords
chitosan
excipient
silicon dioxide
dosage forms
solid dosage
Prior art date
Application number
DK05019082T
Other languages
English (en)
Inventor
Adnan Dr Badwan
Mayyas Dr Al-Remawi
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of DK1759711T3 publication Critical patent/DK1759711T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DK05019082T 2005-09-02 2005-09-02 Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer DK1759711T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05019082A EP1759711B1 (en) 2005-09-02 2005-09-02 Chitosan-silicon dioxide coprecipitate and use as excipient in solid dosage forms

Publications (1)

Publication Number Publication Date
DK1759711T3 true DK1759711T3 (da) 2008-10-27

Family

ID=35601884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05019082T DK1759711T3 (da) 2005-09-02 2005-09-02 Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer

Country Status (12)

Country Link
US (1) US20080214677A1 (da)
EP (1) EP1759711B1 (da)
KR (1) KR20080048465A (da)
CN (1) CN101267839A (da)
AT (1) ATE397941T1 (da)
BR (1) BRPI0615612A2 (da)
CA (1) CA2616470A1 (da)
DE (1) DE602005007491D1 (da)
DK (1) DK1759711T3 (da)
EA (1) EA200800733A1 (da)
ES (1) ES2307099T3 (da)
WO (1) WO2007025715A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2016946B1 (en) * 2007-07-18 2013-02-27 The Jordanian Pharmaceutical Manufacturing Co. Chitosan silicon dioxide coprecipitate composition for use as a therapeutically active agent
TWI400088B (zh) * 2010-12-17 2013-07-01 Univ Nat Chiao Tung 藥物載體原料及其製備方法和使用方法
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549739A (en) * 1993-11-26 1996-08-27 Nippon Suisan Kaisha, Ltd. Wood modifier composition
CA2212300A1 (en) * 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6833487B2 (en) * 2000-04-25 2004-12-21 The Procter & Gamble Company Articles comprising a cationic polysaccharide and silica
EP1586313A1 (en) * 2004-04-07 2005-10-19 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Pharmaceutical composition with metoclopramide and process for its preparation

Also Published As

Publication number Publication date
ES2307099T3 (es) 2008-11-16
CA2616470A1 (en) 2007-03-08
KR20080048465A (ko) 2008-06-02
US20080214677A1 (en) 2008-09-04
EP1759711B1 (en) 2008-06-11
BRPI0615612A2 (pt) 2011-05-24
ATE397941T1 (de) 2008-07-15
WO2007025715A1 (en) 2007-03-08
EA200800733A1 (ru) 2008-06-30
CN101267839A (zh) 2008-09-17
EP1759711A1 (en) 2007-03-07
DE602005007491D1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
UY29856A1 (es) Forma cristalina 8d del clorhidrato de la ivabradina, su procedimiento de preparación, y las composiciones farmaceuticas que la contienen
CY1114190T1 (el) Νεα μορφη χορηγησης της ρασεκαδοτριλης
CL2009000380A1 (es) Compuestos derivados de heterociclos, moduladores de beta-amiloide; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la enfermedad de alzheimer, angioplastia cerebral amiloide, demencia multiinfarto, sindrome de down, entre otras.
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
ATE474561T1 (de) Orodispersible pharmazeutische zusammensetzung für die orale, oromukosale oder sublinguale verabreichung von agomelatin
SMT201200014B (it) Nalmefene cloridrato diidrato.
ATE429906T1 (de) Trockene aripiprazolformulierungen
EP1749517B8 (en) Stable pharmaceutical composition comprising linezolid form IV
WO2006138048A3 (en) Formulations comprising fluphenazine or derivatives thereof
NO20082097L (no) Farmasoytiske sammensetninger
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
EA200700484A1 (ru) Фармацевтическая композиция толтеродина с пролонгированным высвобождением
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
WO2006091836A8 (en) Formulations of ladostigil tartrate
ATE548349T1 (de) In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
DK1868581T3 (da) Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler
SI1742927T1 (sl) Derivati butanojske kisline, postopki za pripravo le-teh, farmacevtski sestavki, ki jih vsebujejo in terapevtske uporabe le-teh
NO20084476L (no) Polymere mastiseringsmasser for kosmetiske produkter
ATE479427T1 (de) Pharmazeutische zusammensetzung mit candesartan- cilexetil
HK1106447A1 (en) Liquid allergy vaccine formulation for oromucosal administration
TW200640932A (en) Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
DK1759711T3 (da) Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer
ITRM20050531A1 (it) Dispositivo medico comprendente lactobacilli e simeticone per il trattamento delle patologie gastrointestinali.
DE602004022515D1 (de) Fenofibrate tablett und verfahren zur herstellung
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel